Dissociation between titer of anti-ganglioside antibody and severity of symptoms in a case of Guillain–Barré syndrome with treatment-related fluctuation-Reference-Cited by-同舟云学术

Dissociation between titer of anti-ganglioside antibody and severity of symptoms in a case of Guillain–Barré syndrome with treatment-related fluctuation

Published:2003-06 Issue:1-2 Volume:210 Page:105-108
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Inoue Nami,Kunishige Makoto,Yoshida Sumiko,Oshima Yasushi,Ohnishi Yoshiaki,Kuroda Yasuhiro,Asano Atsuko,Yoshino Hiide,Matsumoto Toshio,Mitsui Takao

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference23 articles.

1. The Guillain–Barré syndrome;Ropper;N. Engl. J. Med.,1992

2. Serum antibodies to gangliosides in Guillain–Barré syndrome;Ilyas;Ann. Neurol.,1988

3. Pathogenesis of Guillain–Barré syndrome;Hughes;J. Neuroimmunol.,1999

4. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain–Barré syndrome: clinical and immunohistochemical studies;Chiba;Neurology,1993

5. Two species of antiganglioside antibodies in a patient with a pharyngeal–cervical–brachial variant of Guillain–Barré syndrome;Mizoguchi;J. Neurol. Neurosurg. Psychiatry,1994

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Glycolipid Antibody Examination in Five EAE Models and Theiler’s Virus Model of Multiple Sclerosis: Detection of Anti-GM1, GM3, GM4, and Sulfatide Antibodies in Relapsing-Remitting EAE;International Journal of Molecular Sciences;2023-08-18

2. Notch signaling dependent monocyte conversion alleviates immune-mediated neuropathies by regulating RBP-J/NR4A1 axis;Journal of Autoimmunity;2022-12

3. A Rare Case of Guillain–Barré Syndrome with Signs of Meningeal Irritation and Treatment-Related Fluctuations/Relapse;Journal of Pediatric Neurology;2022-08-24

4. Association between serum low‐density neutrophils and acute‐onset and recurrent Guillain–Barré syndrome;Brain and Behavior;2021-12-10